Success in the pharma market - seizing opportunities
Few global markets are growing as strongly as
pharmaceuticals. The newly upgraded Avery Dennison
plant at Bourg-de-Thizy offers the specialised
product range and the reliable quality needed
to seize important business opportunities.
The upgraded Avery Dennison plant at Bourg-de-Thizy
gives converters the innovative and reliable pharma
range they need to build new business opportunities.
Growing demand has made pharmaceuticals a profitable
arena but challenges include counterfeit drugs,
more generic suppliers, and a constant flow of
new regulations. High quality and innovative labelling
products are essential when overcoming these challenges,
which is why Avery Dennison has made a significant
investment in its pharma plant at Bourg-de-Thizy.
The plant produces products that meet very specific
sector demands including good adhesion to strongly
curved surfaces, elimination of contamination
and tolerance to chemicals and temperature extremes.
Advanced options include luminescent label materials.
Major new production facilities
In all pharma-related production quality control
is paramount, and converters can have confidence
that products created using materials from Bourg-de-Thizy
will meet strict criteria. The plant has been
upgraded to meet the high pharma quality requirements.
Major development work has successfully eliminated
potential contamination threats with measures
such as sealed doors, wood-free pallets/bags and
a filtered ventilation system. On the production
line itself, a web cleaner system eliminates dirt
and contamination underneath laminates. Product
defects as small as 0.17mm can now be detected,
with a detection rate of 100% on 0.34mm defects.
Plant manager Didier Francois-Pierre is clear
about the benefits:
"This has been a very productive period,
during which the team at the plant has created
a cutting-edge pharmaceuticals facility. We now
have the systems needed not only to continue innovating
but also to prove conclusively both to label converters
and to end customers that products meet very precise
specifications."
Breadth of choice
Approval for a single self-adhesive pharmaceutical
labelstock can take one to three years, and no
element of the laminate can then be changed. That's
why the breadth of the range made at Bourg-de-Thizy
is extremely significant.
Find out more about our pharmaceuticals range
at europe.fasson.com/pharma
Training opportunities
Our 2011 training program is now being planned
and it will include many topics of importance
to converters.
You
can register right now and we will send
you more details as soon as they are available.
It is a highly effective way to acquire, or further
develop, your skills in pharmaceutical labelling
and identify its business potential and real opportunities.
Topics covered will include the following:
- What the pharmaceutical industry needs from
converters
- What the product range is and how it can be
exploited
- How to guarantee the quality assurance needed
- How the new Bourg-de-Thizy plant operates
(site visit).
|
